ARTICLE | Clinical News
BiDil regulatory update
November 8, 2004 8:00 AM UTC
NTMD submitted data to the FDA from the U.S. Phase III A-HeFT trial in over 1,050 African American patients in support of an amendment to the Bidil NDA. NTMD and the agency had an understanding that t...